Sui, Lufei
Wang, Suming
Ganguly, Debolina
El Rayes, Tyler P. http://orcid.org/0000-0002-9935-388X
Askeland, Cecilie
Børretzen, Astrid
Sim, Danielle
Halvorsen, Ole Johan
Knutsvik, Gøril
Arnes, Jarle
Aziz, Sura
Haukaas, Svein
Foulkes, William D. http://orcid.org/0000-0001-7427-4651
Bielenberg, Diane R.
Ziemys, Arturas
Mittal, Vivek http://orcid.org/0000-0002-4764-7413
Brekken, Rolf A. http://orcid.org/0000-0003-2704-2377
Akslen, Lars A.
Watnick, Randolph S. http://orcid.org/0000-0001-5755-5638
Article History
Received: 11 June 2021
Accepted: 15 December 2022
First Online: 27 December 2022
Competing interests
: R.S. Watnick is a co-founder of, and consultant for, Vigeo Therapeutics, which has licensed technology from Boston Children’s Hospital. The work in this report was done independently and without financial support from Vigeo. The remaining authors declare no other competing interests.